A novel technique to assess flow-mediated vasodilation

Journal of the American College of Cardiology

Volumn 44, Issue 7, 2004, Pages 1478-1480

  Fazel, Shafie ^a   Weisel, Richard D ^a   Verma, Subodh ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b Canada M5G 2C4 ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE;

ARTERY OCCLUSION; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL; BRACHIAL ARTERY; CELL FUNCTION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; ECHOGRAPHY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEALTH SURVEY; HUMAN; HYPEREMIA; MONITORING; NOTE; PRIORITY JOURNAL; RISK FACTOR; SCINTIGRAPHY; TECHNIQUE; VALIDATION PROCESS; VASODILATATION;

EID: 4644256298     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.07.019     Document Type: Editorial

References (43)

1. Dupuis J, Arsenault A, Meloche B, Harel F, Stahiloae C, Grégoire J. Quantitative hyperemic reactivity in opposed limbs during myocardial perfusion imaging: a new marker for coronary artery disease. J Am Coll Cardiol 2004;44:1473-7.
2. R. Joannides, W.E. Haefeli, L Linder Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo Circulation 91 1995 1314 1319
3. J.P. Cooke, E. Rossitch Jr, N.A. Andon, J. Loscalzo, V.J. Dzau Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator J Clin Invest 88 1991 1663 1671
4. + channels Circulation 103 2001 1992 1998
5. + current in vascular endothelial cells Nature 331 1988 168 170
6. A.J. Bank, R. Sih, K. Mullen, M. Osayamwen, P.C. Lee Vascular ATP-dependent potassium channels, nitric oxide, and human forearm reactive hyperemia Cardiovasc Drugs Ther 14 2000 23 29
7. H.M. Farouque, I.T. Meredith Relative contribution of vasodilator prostanoids, NO, and KATP channels to human forearm metabolic vasodilation Am J Physiol Heart Circ Physiol 284 2003 H2405 11
8. + channels does not affect reactive hyperemia in human forearm Am J Physiol Heart Circ Physiol 284 2003 H711 8
9. D. Sun, A. Huang, C.J Smith Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice Circ Res 85 1999 288 293
10. B. Hedblad, M. Ogren, L. Janzon, S.O. Isacsson, S.E. Lindell Low pulse-wave amplitude during reactive leg hyperaemia: an independent, early marker for ischaemic heart disease and death Results from the 21-year follow-up of the prospective cohort study 'Men born in 1914,' Malmo, Sweden J Intern Med 236 1994 161 168
11. P.E. Szmitko, C.H. Wang, R.D. Weisel, G.A. Jeffries, T.J. Anderson, S. Verma Biomarkers of vascular disease linking inflammation to endothelial activation: part II Circulation 108 2003 2041 2048
12. P.E. Szmitko, C.H. Wang, R.D. Weisel, J.R. de Almeida, T.J. Anderson, S. Verma New markers of inflammation and endothelial cell activation: part I Circulation 108 2003 1917 1923
13. J.A. Vita, J.F. Keaney Jr Endothelial function: a barometer for cardiovascular risk? Circulation 106 2002 640 642
14. R. Pedrinelli, G. Dell'Omo, A Gimelli Myocardial and forearm blood flow reserve in mild-moderate essential hypertensive patients J Hypertens 15 1997 667 673
15. O.P. Pitkanen, O.T. Raitakari, T Ronnemaa Influence of cardiovascular risk status on coronary flow reserve in healthy young men Am J Cardiol 79 1997 1690 1692
16. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
17. N. Gokce, J.F. Keaney Jr., L.M. Hunter, M.T. Watkins, J.O. Menzoian, J.A. Vita Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study Circulation 105 2002 1567 1572
18. N. Gokce, J.F. Keaney Jr., L.M Hunter Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease J Am Coll Cardiol 41 2003 1769 1775
19. J.P. Halcox, W.H. Schenke, G Zalos Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658
20. T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, T. Munzel Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease Circulation 104 2001 2673 2678
21. T. Neunteufl, S. Heher, R Katzenschlager Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain Am J Cardiol 86 2000 207 210
22. F. Perticone, R. Ceravolo, A Pujia Prognostic significance of endothelial dysfunction in hypertensive patients Circulation 104 2001 191 196
23. V. Schachinger, M.B. Britten, A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
24. J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes Jr., A. Lerman Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction Circulation 101 2000 948 954
25. P.V. Targonski, P.O. Bonetti, G.M. Pumper, S.T. Higano, D.R. Holmes Jr., A. Lerman Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events Circulation 107 2003 2805 2809
26. P.M. Ridker, N. Rifai, M Clearfield Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
27. P.M. Ridker, C.H. Hennekens, J.E. Buring, N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
28. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
29. S. Verma, C.H. Wang, S.H Li A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 2002 913 919
30. S. Verma, E.T. Yeh C-reactive protein and atherothrombosis - beyond a biomarker: an actual partaker of lesion formation Am J Physiol Regul Integr Comp Physiol 285 2003 R1253 6
31. C.H. Wang, S.H. Li, R.D Weisel C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle Circulation 107 2003 1783 1790
32. S. Verma, S.H. Li, M.V Badiwala Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 2002 1890 1896
33. M.A. Borger, G. Cohen, K.J Buth Multiple arterial grafts Radial versus right internal thoracic arteries Circulation 98 1998 II7 13
34. S. Fazel, H.R. Mallidi, M.P Pelletier Radial artery use is safe in patients with moderate to severe left ventricular dysfunction Ann Thorac Surg 75 2003 1414 1421
35. S.E. Fremes, G.T. Christakis, D.F. Del Rizzo, A. Musiani, H. Mallidi, B.S. Goldman The technique of radial artery bypass grafting and early clinical results J Card Surg 10 1995 537 544
36. S.E. Fremes Multicenter Radial Artery Patency Study (RAPS) Study design Control Clin Trials 21 2000 397 413
37. M. Bottcher, M.M. Madsen, J Refsgaard Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve Circulation 103 2001 1109 1114
38. M.C. Corretti, T.J. Anderson, E.J Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
39. K.J. Mather, S. Verma, T.J. Anderson Improved endothelial function with metformin in type 2 diabetes mellitus J Am Coll Cardiol 37 2001 1344 1350
40. S. Verma, S.R. Raj, L. Shewchuk, K.J. Mather, T.J. Anderson Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers: randomized evaluation of rofecoxib versus naproxen on endothelium-dependent vasodilatation Circulation 104 2001 2879 2882
41. G. O'Driscoll, D. Green, R.R. Taylor Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1997 1126 1131
42. E.S. Stroes, H.A. Koomans, T.W. de Bruin, T.J. Rabelink Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication Lancet 346 1995 467 471
43. C.B. Treasure, J.L. Klein, W.S Weintraub Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 1995 481 487